skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > naphthyridine derivative > quinoxaline derivative > 2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-n-phenylacetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > naphthyridine derivative > quinoxaline derivative > 2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-n-phenylacetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > naphthyridine derivative > quinoxaline derivative > 2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-n-phenylacetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > naphthyridine derivative > quinoxaline derivative > 2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-n-phenylacetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > naphthyridine derivative > quinoxaline derivative > 2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-n-phenylacetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > naphthyridine derivative > quinoxaline derivative > 2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-n-phenylacetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > naphthyridine derivative > quinoxaline derivative > 2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-n-phenylacetamide

Preferred term

2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-n-phenylacetamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C22H24N4O2S

inchi

  • InChI=1S/C22H24N4O2S/c1-15-12-26(13-16(2)28-15)21-22(25-19-11-7-6-10-18(19)24-21)29-14-20(27)23-17-8-4-3-5-9-17/h3-11,15-16H,12-14H2,1-2H3,(H,23,27)

inchikey

  • LDTACDBKWNCJPQ-UHFFFAOYSA-N

mass

  • 408.518

monoisotopicmass

  • 408.16200

smiles

  • CC1CN(CC(O1)C)C2=NC3=CC=CC=C3N=C2SCC(=O)NC4=CC=CC=C4

subset

  • 2_STAR

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:93892

Download this concept:

RDF/XML TURTLE JSON-LD